EDRH
IBIO icon

Edmond de Rothschild Holding’s iBio IBIO Stock Holding History

Edmond de Rothschild Holding’s Portfolio IBIO Stock Details IBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-400
Closed -$3.56K – 771
2022
Q4 		$3.56K Hold
400
– – ﹤0.01% 767
2022
Q3 		$34K Hold
400
– – ﹤0.01% 705
2022
Q2 		$53K Hold
400
– – ﹤0.01% 658
2022
Q1 		$86K Hold
400
– – ﹤0.01% 608
2021
Q4 		$110K Hold
400
– – ﹤0.01% 617
2021
Q3 		$212K Hold
400
– – ﹤0.01% 530
2021
Q2 		$302K Hold
400
– – 0.01% 480
2021
Q1 		$308K Buy
400
+200
+100% +$174K 0.01% 433
2020
Q4 		$105K Hold
200
– – ﹤0.01% 503
2020
Q3 		$203K Buy
+200
New +$290K 0.01% 398

Other funds holding IBIO

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Edmond de Rothschild Holding's IBIO Position: Q1 2023 in Review

Edmond de Rothschild Holding sold out of iBio (IBIO) in Q1 2023, closing a stake of 400 shares — an estimated $3.56K sold.

Edmond de Rothschild Holding first reported a position in IBIO in Q3 2020 and held it in 10 quarters. The position peaked at $308K in Q1 2021. 29 funds tracked by Wall St. Rank hold IBIO as of Q1 2023.

  • Edmond de Rothschild Holding reported no remaining iBio position as of Q1 2023 after selling out during the quarter.
  • Edmond de Rothschild Holding sold 400 iBio shares in Q1 2023, an estimated $3.56K.
  • Edmond de Rothschild Holding first reported a position in iBio in Q3 2020 and held it in 10 quarters.
  • Edmond de Rothschild Holding's iBio position peaked at $308K in Q1 2021.
  • 29 funds tracked by Wall St. Rank held iBio as of Q1 2023.

Based on Edmond de Rothschild Holding's 13F filing for Q1 2023, filed 11 May 2023.